Spain: GAMESA shareholders set to pass Siemens merger, creating windpower giant
Shareholders for wind turbine maker GAMESA will gather this Tuesday to vote on the imminent merger of the company with German group Siemens’ own wind-power division. Should the vote go as expected, the merger would result in the world’s largest maker and operator of wind-power equipment.
The Spanish company’s shareholders will vote on whether to proceed with their purchase of Siemens Wind Holdco. The deal would see Siemens’ own shareholders holding on to up to 59% of the final company’s social capital.
Should the vote succeed, the merger will begin its necessary revision process for authorization from Spanish and European competition regulators, as well as confirmation from the National Stock Market Commission (CNMV) that Siemens will not be forced to launch an IPO over their wind division. The merger would create a wind-power behemoth, with over 69 GW of installed capacity and orders for over 20,200 MW in all five continents, and valued at over 10,000 euros.
Full Content: Expansión
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Justice Department Moves to End NCAA Transfer Rule
May 30, 2024 by
CPI
Kenya’s Competition Authority Proposes Tougher Regulations on Big Tech
May 30, 2024 by
CPI
KKR Secures EU Antitrust Approval for $24 Billion Acquisition of Telecom Italia’s Fixed-Line Network
May 30, 2024 by
CPI
European Court Sides with Tech Giants in Italian Regulatory Dispute
May 30, 2024 by
CPI
US Steel and Nippon Steel Secure International Approvals for $14.9B Merger
May 30, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 31, 2024 by
CPI
AI and Antitrust Considerations in U.S. Health Care
May 31, 2024 by
CPI
Uncertainty in the Bottom Line: New Antitrust Scrutiny and Enforcement in Private Equity Transactions
May 31, 2024 by
CPI
Effecting M&A Diligence When Competitors Are Involved
May 31, 2024 by
CPI
AI, Pharmaceutical Sector, and EU Competition Law and Policy: What Does the Future Look Like?
May 31, 2024 by
CPI